Novacyt Investor Relations Material
Latest events
H1 2024
Novacyt
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Novacyt S.A.
Access all reports
Novacyt S.A. is a biotechnology company focused on the development, manufacturing, and commercialization of clinical diagnostic products. It operates primarily through its business units, including Primerdesign, Lab21 Products, and IT-IS International. The company specializes in in vitro and molecular diagnostics, offering a wide range of assays, reagents, and PCR devices for detecting various infectious diseases, including pathogens responsible for respiratory, gastrointestinal, and insect-borne illnesses. Novacyt serves a global market, providing its products to public hospitals, central laboratories, and private testing facilities. The company is headquartered in Camberley, United Kingdom, and its shares are listed on the Euronext Growth.
Key slides for Novacyt S.A.
H1 2024
Novacyt S.A.
H2 2023
Novacyt S.A.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ALNOV
Country
🇫🇷 France